Table of Contents
Chapter 1 Introduction
- Bone Grafting
- Biological Activity of Bone Grafts
- Current Bone Graft Technologies and Applications
- Autografts
- Advantages of Autografts
- Limitation of Autografts
- Machined Allografts
- Advantages and Limitations of Machined Allografts
- Synthetic Bone Graft Substitutes
- Advantages and Limitations of Synthetic Bone Graft Substitutes
- Demineralised Bone Matrix
- Advantages and Disadvantages of Demineralised Bone Matrices
- Bone Morphogenic Proteins
- Advantages and Limitations of Bone Morphogenic Proteins
- Comparative Properties of Autografts and Allografts
- Comparative Properties of Synthetic and Cell-Based Bone Graft Substitutes
Chapter 2 Orthopaedic Procedures and Bone Graft Utilisation
- Bone Graft Utilisation in Orthopaedic Applications (Europe, 2004)
- Total Number of Spinal Fusion Procedures in Europe, 2004
- Total Number of Spinal Fusion Procedures by Selected Geographic Regions in the Europe, 2004
- Total Number of Spinal Fusion Procedures by Anatomy, Europe, 2004
Chapter 5 Bone Morphogenic Proteins (BMP) Market
- Market Drivers and Restraints
- Market Opportunities
- End-User Trends
- Industry Challenges
- Market Challenges
- BMP Products
- rhBMP-2/ACS (marketed as InFUSE Graft in the U.S., and as InductOS in Europe)
- History of rhBMP-2/ACS
- Product Description
- Development of rhBMP/ACS
- Preclinical Studies
- Clinical Studies
- Indications and Contradictions
- Development of InductOS in Europe
- OP-1
- Development of OP-1
- Product Description
- Preclinical Studies
- Clinical Studies
- FDA Indications and Contradictions
- MP52
- Product Description
- History of Development
- Preclinical and Clinical Studies
- FDA Status
- Pricing Analysis
- Pricing Forecasts for BMPs
- Market Size for BMPs
- Unit Shipments of BMPs
- Analysis of Unit Shipment of BMPs in the U.S.
- European BMP Market by Geographic Region, 2004
- Surgeons Prospective
View Cart
